Women and headache: A treatment approach based on life stages

Cleveland Clinic Journal of Medicine

Volumn 69, Issue 6, 2002, Pages 488-500

  Mannix, Lisa K ^a   Diamond, Merle ^a   Loder, Elizabeth ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; AMITRIPTYLINE; ANALGESIC AGENT; BUTALBITAL; CAFFEINE; CYCLOOXYGENASE 2 INHIBITOR; CYPROHEPTADINE; DICHLORALPHENAZONE; DIHYDROERGOTAMINE; DIHYDROERGOTAMINE MESILATE; ERGOTAMINE DERIVATIVE; ERGOTAMINE TARTRATE; IBUPROFEN; ISOMETHEPTENE MUCATE; METHYSERGIDE; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PROPRANOLOL; RIZATRIPTAN; SEROTONIN 1 AGONIST; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VERAPAMIL; ZOLMITRIPTAN;

ADOLESCENT; ADULT; CHILD; CHRONOLOGY; CONSTIPATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG FORMULATION; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HORMONAL REGULATION; HUMAN; HYDRATION; HYPOTENSION; LIFE CYCLE; MIGRAINE; NAUSEA; PATHOPHYSIOLOGY; PREGNANCY; REVIEW; SIDE EFFECT; VERTIGO; WEIGHT GAIN;

EID: 0036085827     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.6.488     Document Type: Review

References (108)

1. Quality of life assessment in patients with headache
2. Quality of life and well-being of headache patients: Measurement by the medical outcomes study instrument
3. Measuring the functional status and well-being of patients with migraine headache
4. Healthcare resource use and costs associated with migraine in a managed healthcare setting
5. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors
6. Migraine diagnosis and treatment: Results from the American Migraine Study II
7. Epidemiology of tension-type headache
8. The burden of migraine: A review of cost to society
9. Interrelationships of neurochemicals, estrogen, and recurring headache
10. The role of sex hormones in headache
11. Menstrual migraines: Etiologies, treatment, and relationship to premenstrual syndrome
12. Gender effects in pharmacokinetics and pharmacodynamics
13. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
14. Sumatriptan for the range of headaches in migraine sufferers: Results of the Spectrum Study
15. Migraine and muscle contraction headaches: A continuum
16. The relationship of headache symptoms with severity and duration of attacks
17. A population-based analysis of the diagnostic criteria of the International Headache Society
18. The utility of neuroimaging in the evaluation of headache in patients with normal neurologic exams
19. Sensitization of meningeal sensory neurons and the origin of headaches
20. Cardiovascular and neuronal responses to head stimulation reflect central sensitization and cutaneous allodynia in a rat model of migraine
21. Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons
22. An association between migraine and cutaneous allodynia
23. Brainstem activation in human migraine attacks
24. 2 serotonin receptor: A possible mechanism of transformed migraine
25. Alteration of central excitation circuits in chronic headache and analgesic misuse
26. Modulation of excitatory amino acid pathways: A possible therapeutic approach to chronic daily headache associated with analgesic drug abuse
27. Serum beta-endorphin increase after intravenous histamine treatment of chronic daily headache
28. Cellular adaptation in migraineurs with chronic daily headache
29. Evaluation and management strategies for migraine
30. Evidence-based guidelines for migraine headache: Behavioral and physical treatments
31. Imagery coping strategies in the treatment of migraine
32. Migraine: An exploratory treatment application of programmed behavior therapy techniques
33. Results of a controlled, experimental, outcome study of nondrug treatments for the control of migraine headaches
34. Differential effects of training in relaxation and stress-coping in patients with migraine
35. Brief psychological training procedures in migraine treatment
36. Biofeedback and relaxation in the treatment of migraine headaches: Comparative effectiveness and physiological correlates
37. Biofeedback control of migraine headaches: A comparison of two approaches
38. Skin temperature biofeedback and migraine
39. Evidence based guidelines for migraine headache: Overview of program description and methodology
40. Migraine prophylactic drugs: Proof of efficacy, utilization, and cost
41. Fluoxetine and migraine: Comparison of double-blind trials
42. Disability assessment as a basis for stratified care
43. Current treatment strategies for migraine disorder
44. Stratified care vs. step care strategies for migraine: The Disability in Strategies of Care (DISC) Study: A randomized trial
45. Migraine in school children
46. An update on the epidemiology of migraine
47. Multicenter prospective evaluation of proposed pediatric migraine revisions to the IHS criteria
48. Ibuprofen or acetaminophen for the acute treatment of migraine in children-A double-blind, randomized, placebo-controlled, crossover study
49. Intranasal sumatriptan for the acute treatment of migraine
50. Migraine and reproductive hormones throughout the menstrual cycle
51. Estrogen, progestins, and headache
52. Sex hormones and headaches
53. A one year tolerability and efficacy of sumatriptan nasal spray for adolescents with migraine: Results of a multicenter open-label study
54. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents
55. Clinical profile of rizatriptan 5 mg in adolescent migraineurs
56. Headaches in adolescents. Diagnosis and management
57. Health-related quality of life impairments in women with headache
58. Burden of migraine in the United States: Disability and economic costs
59. Treatment of mild headache in disabled migraine sufferers: Results of the Spectrum Study
60. Menstrual migraine is not pathological related to premenstrual syndrome
61. The premenstrual syndrome belongs in the diagnostic criteria for menstrual migraine
62. Ovarian suppression with the gonadotropin-releasing hormone agonist gosereline (Zoladex) in management of the premenstrual tension syndrome
63. Efficacy of depot leuprolide in premenstrual syndrome: Effect of symptom severity and type in a controlled trial
64. Induced anovulation as a treatment of premenstrual syndrome: A double-blind cross-over study with GnRH-agonist versus placebo
65. The premenstrual syndrome: Effects of medical ovariectomy
66. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled trial
67. Sertraline in the treatment of premenstrual dysphoric disorder
68. Paroxetine as a treatment for premenstrual dysphoric disorder
69. Menstruation, sex hormones, and migraine
70. The role of estradiol withdrawal in the etiology of menstrual migraine
71. Treatment of menstruation associated migraine headache with subcutaneous sumatriptan
72. The efficacy of sumatriptan in menstrual migraine-A prospective study
73. Rizatriptan in the treatment of menstrual migraine
74. Zolmitriptan (Zomig, 311C90), a novel dual central and peripheral 5HT1B/1D agonist: An overview of efficacy
75. Treatment of menstruation-associated migraine with non-prescription combination of acetaminophen, aspirin, and caffeine: Results from three randomized, placebo-controlled studies
76. Prophylactic effects of naproxen sodium on perimenstrual headache: A double-blind placebo controlled study
77. Naproxen sodium in menstrual migraine prophylaxis: A double-blind placebo controlled study
78. A pilot study of oral sumatriptan in the intermittent prophylaxis of menstruation-related migraine
79. Naratriptan as short-term prophylaxis of menstrually-associated migraine: A randomized, double-blind, placebo-controlled study
80. Magnesium prevention of premenstrual migraine: A placebo controlled study
81. Management of menstrual migraine
82. Tamoxifen in the treatment of menstrual migraine
83. Prevention of migrainous headaches by tamoxifen
84. Prevention of menstrual migraine by percutaneous oestradiol
85. Menstrual migraine: A double-blind trial of percutaneous estradiol
86. Oral contraception and risk of cerebral thromboembolic attack: Results of a case-control study
87. Stroke in users of low-dose oral contraceptives
88. Ischaemic stroke and combined oral contraceptives; Results of an international, multicentre, case-control study
89. Oral contraceptives, pregnancy, and the risk of cerebral thromboembolism: The influence of diabetes, hypertension, migraine, and previous thrombotic disease
90. Migraine and stroke in young women: Case-control study
91. Case-control study of migraine and risk of ischaemic stroke in young women
92. Migraine and pregnancy: A prospective study in 703 women after delivery
93. A study of migraine in pregnancy
94. Headache during pregnancy and in the postpartum: A prospective study
95. Relaxation therapy in migraine and chronic tension headache
96. Prophylaxis of migraine and mixed headache. A randomized controlled study
97. Maintenance of effects in the nonmedical treatment of headaches during pregnancy
98. Drugs in Pregnancy and Lactation
99. The sumatriptan pregnancy registry: An ongoing prospective observation epidemiologic study to monitor birth outcomes following sumatriptan use in pregnancy
100. Pregnancy outcome following prescription for sumatriptan
101. Pregnancy outcome following first trimester exposure to sumatriptan
102. Delivery outcome in women who use drugs for migraine during pregnancy with special reference to sumatriptan
103. Headaches and women: Treatment of the pregnant and lactating migraineur
104. Preventative treatment of migraine: An overview
105. The transfer of drugs and other chemicals into human milk
106. Distribution and excretion of sumatriptan in human milk
107. Characteristics of headache at menopause: A clinico-epidemiologic study
108. The relationship of headache frequency to hormone dose in migraine